Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when TMO files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: TMO THERMO FISHER SCIENTIFIC INC. 8-K

Thermo Fisher completes acquisition of Clario Holdings

Filed March 24, 2026 · Period ending March 24, 2026 · ~1 min read

2 key changes 1 high relevance 1 section

Key Changes

  • high

    Thermo Fisher closed its acquisition of Clario Holdings, Inc. on March 24, 2026, expanding its business portfolio through the addition of Clario's operations.

    Item 8.01 verify on EDGAR →
  • medium

    The company issued a press release announcing the transaction completion, with full details provided in the attached exhibit.

    Exhibit 99.1 view on EDGAR →

Summary

Thermo Fisher Scientific completed its acquisition of Clario Holdings on March 24, 2026, marking the close of a previously announced deal. Clario operates in the clinical trial technology and services space, providing cardiac safety, respiratory, and ePRO solutions to pharmaceutical and biotech companies. This acquisition expands Thermo Fisher's capabilities in the clinical research services market, complementing its existing life sciences and diagnostics businesses.

For retail investors, this completion represents the deployment of capital into a strategic growth area. The key question is whether Clario's operations will be accretive to earnings and how quickly integration synergies can be realized. Watch for management commentary on the acquisition's financial impact in upcoming earnings calls, particularly any updates on revenue contribution and integration costs in Q1 and Q2 2026 results.

Section-by-Section Diff

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

Thermo Fisher filed an 8-K attaching a press release dated March 24, 2026; no material event details disclosed in the filing body.

1 Added
Added Press release attachment medium

Added in current filing · verify on EDGAR →

99.1 Press Release of Thermo Fisher Scientific Inc., dated March 24, 2026

The 8-K references an attached press release dated March 24, 2026. The filing body provides no details about the content or subject matter of the press release, so the nature and materiality of the disclosed event cannot be determined from this document alone.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify